CURE speaks with Dr. Susan O'Brien, on behalf of the Leukemia and Lymphoma Society.
FDA Approves Tibsovo Plus Vidaza For Patients With Newly Diagnosed Acute Myeloid Leukemia
Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression
Will My Daughter Be a Triple-Positive Breast Cancer Pioneer?
Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations